Merck Kgaa (MKGAF) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Merck Kgaa.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.238 Ladies and gentlemen, welcome to the Merck Investor and Analyst Conference call 00:00:05.238 -- 00:00:09.261 on second quarter 2025. As a reminder, 00:00:09.704 -- 00:00:13.569 all participants will be in a listen-only mode. 00:00:13.569 -- 00:00:18.615 I am now handing over to Florian Schrader, Head of Investor Relations, who will 00:00:18.615 -- 00:00:22.921 lead you through this conference. Please go ahead, sir. 00:00:22.921 -- 00:00:28.786 Thank you very much, Heidi, and a heartfelt welcome to the Merck Q2 2025 results call. 00:00:28.786 -- 00:00:31.789 I am Florian Schreder, the Head of Investor Relations at Merck. 00:00:31.789 -- 00:00:36.675 It is my pleasure to be joined today by Belen Garrigio, our Group CEO, and Helene von 00:00:36.675 -- 00:00:39.157 Röder, our Group CFO. 00:00:39.157 -- 00:00:44.563 For the Q&A segment of this call, we will also have Jean-Charles Wirth, CEO Life Science, 00:00:44.563 -- 00:00:49.709 Denny Basohar, CEO Healthcare, and Kai Beckmann, CEO Electronics, with 00:00:49.709 -- 00:00:54.654 us. In the initial minutes of this call, we will guide you through the key slides of 00:00:54.654 -- 00:00:56.276 the presentation. 00:00:56.276 -- 00:00:59.144 Following that, we will be glad to address your questions. 00:00:59.144 -- 00:01:03.432 With that, I would like to hand it over to Belen to begin. 00:01:03.432 -- 00:01:08.502 Thank you, Florian. Welcome, everybody, to our Q2 earnings call. 00:01:08.502 -- 00:01:13.973 And before starting with the highlights of the quarter, I'm happy to remind everybody 00:01:13.973 -- 00:01:19.512 that we just announced the closing of the diversity of surface solutions last week. 00:01:19.512 -- 00:01:22.034 The closure of this transaction 00:01:22.034 -- 00:01:27.499...